Showing results (131-140 of 179) with videos related to
Sort By:
Pageof 18
Molecular Cell|June 28, 2022
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinomaJin Zhou, Jeremy M Simon, Chengheng Liao, et al.European Urology|March 4, 2011
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombusNicholas G Cost, Scott E Delacroix, Joshua P Sleeper, et al.European Urology|January 4, 2022
Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell CarcinomaOscar Reig Torras, Akhilesh Mishra, Alana Christie, et al.Clinical Genitourinary Cancer|December 28, 2020
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a CureBrian Rini, E Jason Abel, Laurence Albiges, et al.Advances in Radiation Oncology|September 22, 2025
Extracranial Palliative Radiation Therapy for Renal Cell CarcinomaYoung Suk Kwon, Eric Hsu, Maggie Stein, et al.Molecular Cancer Research : MCR|May 29, 2012
State of the science: an update on renal cell carcinomaEric Jonasch, P Andrew Futreal, Ian J Davis, et al.ACS Nano|August 20, 2025
Endogenous Targeting of Lipid Nanoparticles to Kidney TumorsAmogh Vaidya, Yun-Chieh Sung, Vanina Toffessi Tcheuyap, et al.Oncoimmunology|June 15, 2018
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapyOsama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2019
Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing RadiationEun-Jin Yun, Chun-Jung Lin, Andrew Dang, et al.Journal for Immunotherapy of Cancer|July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.Pageof 18